Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Drug-induced liver disease.

W Mayoral¹, J H Lewis

¹Division of Gastroenterology, Georgetown University Medical Center, Washington, DC 20007, USA.

Current Opinion in Gastroenterology

|October 7, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

McSART: an iterative model-based, motion-compensated SART algorithm for CBCT reconstruction.

Physics in medicine and biology·2019

Same author

A prospective gating method to acquire a diverse set of free-breathing CT images for model-based 4DCT.

Physics in medicine and biology·2018

Same author

SU-E-J-210: Lung Tumor Target Volume Contours on EPID Cine Mode Images.

Medical physics·2017

Same author

3D fluoroscopic image estimation using patient-specific 4DCBCT-based motion models.

Physics in medicine and biology·2015

Same author

Letter: antibiotic dose adjustment in patients with advanced liver disease--authors' reply.

Alimentary pharmacology & therapeutics·2013

Same author

Review article: prescribing medications in patients with cirrhosis - a practical guide.

Alimentary pharmacology & therapeutics·2013

Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026

Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026

Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026

Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026

Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026

Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026

See all related articles

This review covers drug-induced liver injury (DILI), including its natural history, placebo effects, and newly identified causes. It also explores hepatoprotective strategies for preventing and treating liver damage from medications like acetaminophen.

Area of Science:

Hepatology
Pharmacology
Toxicology

Background:

Drug-induced liver injury (DILI) is a significant clinical concern.
Understanding the spectrum of DILI, from new agents to established drugs, is crucial.
Placebo effects on liver enzymes warrant careful consideration in clinical trials.

Purpose of the Study:

To provide a comprehensive overview of DILI.
To review newly identified and established drug hepatotoxicity.
To discuss the emerging field of hepatoprotection.

Main Methods:

Literature review and synthesis of current research.
Analysis of clinical and experimental data on DILI.
Examination of hepatoprotective agents and their mechanisms.

Related Experiment Videos

Main Results:

Detailed natural history of DILI.
Discussion of placebo-related elevations in liver enzymes.
Identification of novel and established drugs causing hepatic injury.
Review of hepatoprotective agents, focusing on acetaminophen.

Conclusions:

DILI remains a complex challenge in clinical practice.
Hepatoprotection offers promising avenues for managing drug-induced liver damage.
Continued research is vital for improving DILI prevention and treatment.